California Healthcare Institute Event

Share Article

CHI Program to Highlight Innovations, Obstacles in Oncology Research and Development

WHAT: CHI is hosting California: Uniting Science & Policy to Advance Cancer Care at UCLA, generously sponsored by Cedars-Sinai, Onyx Pharmaceuticals and UCLA Institute for Innovation in Health.

WHO: ▪ Executives with five medical companies: 23andMe, Genentech, Gilead    Sciences, Onyx Pharmaceuticals, Genomic Health ▪ Health and policy experts from CHI, California HealthCare Foundation, Cedars-Sinai, City of Hope, UCLA, UCSF

WHY: In 2012, nearly 144,800 Californians will be diagnosed with cancer. This is equivalent to more than 16 new cases every hour of every day. This year alone, roughly 55,500 people will die of the disease – about 150 people a day, and one out of every four deaths in California is due to cancer. California is also home to many internationally-renowned oncology research institutions, active and respected patient advocacy groups, as well as companies that are developing the next generation of oncology treatments, with 253 products in the pipeline addressing the second leading cause of death in the state.

WHO SHOULD ATTEND: Leaders from California’s biomedical industry, academic research community, entrepreneurs, investors, healthcare providers, policy experts and patient advocates.

WHEN: Thursday, July 12
Registration: 11-11:30 a.m.
Lunch Keynote: 12-1 p.m.
Panel discussions and keynotes:1-5 p.m.
Reception: 5–6 p.m.

WHERE: UCLA's Ackerman Grand Ballroom
308 Westwood Plaza
Los Angeles, CA 90095
For more information, visit

DEADLINE: CHI has reserved a block of rooms at The W Hotel. The deadline to receive the negotiated rate of $299 is Friday, June 15. Please click here or contact the hotel reservation line at 310-208-8765 and provide the California Healthcare Institute name in order to receive the negotiated rate.

Media registration/Heather Chambers

Event registration/Marisa Reinoso

About CHI:
The California Healthcare Institute represents more than 275 leading biotechnology, medical device, diagnostics, and pharmaceutical companies, and public and private academic biomedical research organizations. CHI’s mission is to advance responsible public policies that foster medical innovation and promote scientific discovery. CHI’s website is Follow us on Twitter @calhealthcare, Facebook, LinkedIn and YouTube.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Nicole Beckstrand
Visit website